FDA Investigator Rose Ljean Mary

Rose Ljean Mary has inspections in 3 countries as of 21 Sep 2023. Rose Ljean Mary has collaborated with a combinined 2556 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
26
Last Inspection Date:
21 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
100003875
Country:
India, United States of America, China
Co-Investigator(s):
Addam S Reynolds, Adetutu M Gidado, Alberto A Viciedo, Alexis M Wormington, Alice S Tsao, Amy L Singer, Amy M Cramer, Anita R Michael, Ankur C Patel, Annemarie B Randow, Annemarie Bodnar, Anthony A Charity, Anthony J Donato, Atul J Agrawal, Barbara J Rincon, Barbara Jwilimczyk Macri, Bryan L Mcguckin, Cassandra L Abellard, Craig D Zagata, Daniel J Grabicki, Daniel J Min, Darren S Brown, David A Oluwo, Dhaval H Patel, Dorothy J Denes, Douglas C Kovacs, Dr. Mark J Seaton, PhD, Dr. Zhou Chen (nmi), MD PhD, Emest F Bizjak, Emmanuel J Ramos, Emmanuel Jramos Maldonado, Eric J Cunningham, Erin D Mccaffery, Evgenij A Evdokimov, Farhana Khan, Felix Maldonado, Frank J Marciniak, Frederick Razzaghi, Gajendiran Mahadevan, PhD, Guerlain Ulysse, H Ljamilla Selby, Hala L Selby, Harlan J Howard, Helen Verdel, Heriberto Negron Rivera, Isabel Y Espinosa, James R Birkenstamm, Janet A Rajan, Janete F Guardia, Javier E Santos, Jay B Shah, Jennifer C Adams, Jogy George, Jonathan S Helfgott, Jose M Cayuela, Jose O Hernandez, Joseph F Mcginnis, RPh, Joseph L Despins, PhD, Josh Renzon Ramilo, Jot R Klena, Joy Rkozlowski Klena, Juanita P Versace, Justine Tomasso, Karen E D'orazio, Karthik B Iyer, Karyn M Campbell, Keith M Reilly, Kelli N Hicks, Kellia N Hicks, Kendra L Brooks, Kenneth M Gordon, Kinh Q Mac, Kristina J Donohue, Kristina Mjoyce Pittman, Kristy A Zielny, Krystal O Ogunremi, Lata C Mathew, PhD, Laura Bernard, Lauren L Vajo, LCDR Susan E Polifko, Li Li, Liatte Kreuger, PharmD, Loretta Nemchik, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Margaret M Sands, Maria Estrella, Mary Ddavis Lopez, Matthew R Noonan, Melissa B Libby, Melissa T Roy, Meyer J Slobotsky, Michael A Taylor, Michael R Klapal, Michael Serrano, Michele L Glendenning, Monika Borkowska, Nancy F Scheraga, Nancy M Espinal, Nerizza B Guerin, Nicholas A Violand, Niketa Patel, Nikhil Thakur, Nikki S Ramirez, Odera I Ekwunife, Patrick C Klotzbuecher, Paul L Bellamy, Pushpa S Jayasekara, Rachael O Oyewole, Rajiv R Srivastava, Rebecca E Cluster, Regina T Brown, Robin P Mathew, Russell J Glapion, Sam Pepe, Samir C Gala, Satheesh K Podaralla, Shirley S Wen, Sony Mathews, Sripal R Mada, PhD, Stephen J Koniers, Stephen J Mottola, Susan F Laska, MS, Syeda N Mahazabin, Tamil Arasu, PhD, Tanya R Syffrard, Temar Q Williams, Thomas E Friel, Tonia F Bernard, Torrance J Slayton, Ucheabuchi C Chudi Nwankwor, Victoria Spivak, Vlada Matusovsky, William R Chang, Xiaohan Cai, PhD, Yasamin Ameri, Yiyue Zhang (nmi), PhD, Yvesna C Blaise, Yvins Dezan, Yvonne C Mcknight, Yvonne C Wood

Rose Ljean Mary's Documents

Publish Date Document Type Title
August, 2019 EIR Avantor Performance Materials, LLC - EIR, 2019-08-12
June, 2021 FDA 483 Tris Pharma Inc - Form 483, 2021-06-08
September, 2022 EIR New Jersey Laboratories - EIR, 2022-09-22
September, 2022 FDA 483 New Jersey Laboratories - Form 483, 2022-09-22
September, 2022 FDA 483 Response New Jersey Laboratories - Form 483R, 2022-09-22
November, 2022 FDA 483 Omega Packaging Corporation - Form 483, 2022-11-17
October, 2020 EIR Sannova Analytical LLC - EIR, 2020-10-07
February, 2020 FDA 483 Ohm Laboratories Inc. - Form 483, 2020-02-05
February, 2020 FDA 483 East Orange VA Medical Center - Form 483, 2020-02-27
December, 2022 FDA 483 Health Pharma USA LLC - Form 483, 2022-12-20
September, 2019 EIR Curia New Jersey, LLC - EIR, 2019-09-16
February, 2020 EIR Ohm Laboratories Inc. - EIR, 2020-02-05
August, 2023 FDA 483 SOFIE Co. dba SOFIE - Form 483, 2023-11-02
January, 2022 FDA 483 Bi-Coastal Pharma International - Form 483, 2022-01-14
July, 2021 FDA 483 APPCO PHARMA LLC - Form 483, 2021-08-03
November, 2019 FDA 483 Far Hills Pharmacy - Form 483, 2019-11-14

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more